Disclosure Of Cash Flow Statement [Text Block]

Captor Therapeutics S.A. - Filing #6064395

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
40. 
Description of accounting policy for determining components of cash and cash equivalents [text block]
13.9 
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
39 257 PLN
75 704 PLN
71 036 PLN
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
0 PLN
0 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.